Global Microsclerotherapy Treatment Market Size, Share, and Growth Report 2030

Global Microsclerotherapy Treatment Market

The microsclerotherapy treatment market is expected to grow at a 3.0% CAGR to USD 8,154.6 million by 2028, up from USD 6,829.4 million in 2021.

The market drivers, constraints, and barriers to micro sclerotherapy treatment are explored. This paper analyses recent advances in the field of micro sclerotherapy therapy.

Overview of the Microsclerotherapy Therapy Market

Telangiectasia, a disorder in which blood vessels near the skin’s surface or mucous membranes show as red or pink lines, is treated using microsclerotherapy. Both hereditary and environmental factors influence telangiectasia. Telangiectasia is caused by a combination of variables including age, pregnancy, rosacea, excessive sun exposure, and varicose veins. This illness has no cure, but it can be treated with micro sclerotherapy.

One of the primary factors driving the global micro sclerotherapy market is the increasing prevalence of spider and varicose veins. The comparatively painless therapy, low invasion, great efficacy, reduced post-operative problems, and simple analgesia required during treatment are all important factors moving the global market ahead. Spider veins are a kind of vein.

Read Related:

As a result, another aspect that could benefit the global industry is an increase in the number of aged people. Obesity, the prevalence of unhealthy lifestyles, and heredity may also have an impact on the growth of the worldwide micro sclerotherapy market during the forecast period.

The key factors that could impede worldwide market growth include rising treatment costs, a shortage of surgeon training, and other alternative methods.

Microsclerotherapy Treatment Market: Growth Drivers

The market is expanding because of an increase in female varicose veins.

The rising prevalence of spider and varicose veins is one of the primary factors driving the global market for micro sclerotherapy treatments. Varicose veins are expected to become more common in the coming years. According to the Occupational Health and Safety Research Center, 10% to 30% of persons globally have varicose veins in their lower limbs.

Women are twice as likely as men to have varicose veins. These disorders are substantial risk factors for spider veins in women because of the elevated expression of hormones such as progesterone and estrogen during pregnancy and subsequent pregnancies.

Microsclerotherapy Treatment Market: Segmentation

The global market for microsclerotherapy treatments has been divided into three subcategories: product type, end users, and region.

Sclerosants, sodium tetradecyl sulfate, polidocanol, chromated glycerin, hypertonic glucose, needles, and other products are included in the global microsclerotherapy treatment market. The sclerosants category will dominate the global market in 2021. The market for new sclerosants for spider vein therapy, such as polidocanol, sodium tetradecyl sulfate, and hypertonic saline, is expanding as a result of major producers’ marketing and development activities.

Microsclerotherapy Treatment Market: Competitive Landscape

Some of the main competitors dominating the global micro sclerotherapy treatment market include – Merz Pharma GmbH Co. KGaA, Surgimedix Inc, Troikaa, QOL Medical LLC, McKesson Corporation, Kreussler Inc, Provensis, ltd, Omega Pharmaceuticals, STD Pharmaceuticals Product Ltd, Medtronic Plc, Endo-Flex, Boston Scientific Corporation, and Teleflex Incorporated.

Global Microsclerotherapy Treatment Market is segmented as follows:

By Product Type


Sodium Tetradecyl Sulphate


Chromated Glycerin

Hypertonic Glucose



By End Users


Aesthetic Treatment Clinics


By Region

North America

The U.S.




The UK




Rest of Europe

Asia Pacific




South Korea

Southeast Asia

Rest of Asia Pacific

Latin America



Rest of Latin America

Middle East Africa


South Africa

Rest of Middle East Africa

Contact Us

Zion Market Research

US OFFICE NO +1 (302) 444-0166

US/CAN TOLL-FREE +1 (855) 465-4651

Email: [email protected]

Read Also: